Prostate cancer
People with cancer of the prostate currently have numerous treatment options available to them. But one of the most established, a type of radiation therapy known as brachytherapy, seems to be falling out of favour with clinicians.
This Nature Outline is editorially independent, produced with financial support from a third party. About this content.
Nature is pleased to acknowledge the financial support of J-POPS Study Group, Nihon Medi-Physics, National Hospital Organization Tokyo Medical Center and Translational Research Center for Medical Innovation in producing this Outline. The sponsors retain sole responsibility for the following messages.
The Translational Research Center for Medical Innovation (TRI) was founded in 2002 by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Kobe city to promote academia-originated medical innovation. TRI established the Academic Research Organization (ARO) network in 2013, which is transforming into an Asian ARO network in conjunction with Korea, Taiwan and Singapore. We are promoting data standardization and harmonization globally through alliance with CRIGH (The Clinical Research Initiative for Global Health), the follow-up initiative of OECD. TRI was designated as Certified ECRIN Data Centres the first time outside of EU in 2019, and our aim is to develop an infrastructure to support the launch of global clinical trials of academia-originated projects and to obtain regulatory approval worldwide.
